Viewing Study NCT00492258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-02-23 @ 12:20 PM
Study NCT ID: NCT00492258
Status: COMPLETED
Last Update Posted: 2013-08-12
First Post: 2007-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
Sponsor: Medical Research Council
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II renal cell cancer View
None stage III renal cell cancer View
None stage IV renal cell cancer View
None stage I renal cell cancer View
None clear cell renal cell carcinoma View
None papillary renal cell carcinoma View